期刊文献+

Polymorphisms in NF-κB,PXR,LXR,PPARγ and risk of inflammatory bowel disease 被引量:4

Polymorphisms in NF-κB,PXR,LXR,PPARγ and risk of inflammatory bowel disease
下载PDF
导出
摘要 AIM:To investigate the contribution of polymorphisms in nuclear receptors to risk of inflammatory bowel disease(IBD) . METHODS:Genotypes of nuclear factor(NF) -κB(NFKB1) NFκB-94ins/del(rs28362491) ;peroxisome proliferatoractivated receptor(PPAR) -γ(PPARγ) PPARγPro12Ala(rs1801282) and C1431T(rs 3856806) ;pregnane X receptor(PXR) (NR1I2) PXR A-24381C(rs1523127) ,C8055T(2276707) ,and A7635G(rs 6785049) ;and liver X receptor(LXR) (NR1H2) LXR T-rs1405655-C and T-rs2695121-C were assessed in a Danish case-control study of 327 Crohn's disease patients,495 ulcerative colitis(UC) patients,and 779 healthy controls.Odds ratio(OR) and 95%CI were estimated by logistic regression models. RESULTS:The PXR A7635G variant,the PPARγPro12Ala and LXR T-rs2695121-C homozygous variant genotypes were associated with risk of UC(OR:1.31,95% CI:1.03-1.66,P=0.03,OR:2.30,95%CI:1.04-5.08,P=0.04,and OR:1.41,95%CI:1.00-1.98,P=0.05,respectively) compared to the corresponding homozygous wild-type genotypes.Among never smokers,PXR A7635G and the LXR T-rs1405655-C and T-rs2695121-C variant genotypes were associated with risk of IBD(OR:1.41,95%CI:1.05-1.91,P=0.02,OR:1.63,95%CI:1.21-2.20,P=0.001,and OR:2.02,95%CI:1.36-2.99,P=0.0005,respectively) compared to the respective homozygous variant genotypes.PXR A7635G(rs6785049) variant genotype was associated with a higher risk of UC diagnosis before the age of 40 years and with a higher risk of extensive disease(OR:1.34,95%CI:1.03-1.75 and OR:2.49,95%CI:1.24-5.03,respectively) . CONCLUSION:Common PXR and LXR polymorphisms may contribute to risk of IBD,especially among never smokers. AIM:To investigate the contribution of polymorphisms in nuclear receptors to risk of inflammatory bowel disease(IBD) . METHODS:Genotypes of nuclear factor(NF) -κB(NFKB1) NFκB-94ins/del(rs28362491) ;peroxisome proliferatoractivated receptor(PPAR) -γ(PPARγ) PPARγPro12Ala(rs1801282) and C1431T(rs 3856806) ;pregnane X receptor(PXR) (NR1I2) PXR A-24381C(rs1523127) ,C8055T(2276707) ,and A7635G(rs 6785049) ;and liver X receptor(LXR) (NR1H2) LXR T-rs1405655-C and T-rs2695121-C were assessed in a Danish case-control study of 327 Crohn's disease patients,495 ulcerative colitis(UC) patients,and 779 healthy controls.Odds ratio(OR) and 95%CI were estimated by logistic regression models. RESULTS:The PXR A7635G variant,the PPARγPro12Ala and LXR T-rs2695121-C homozygous variant genotypes were associated with risk of UC(OR:1.31,95% CI:1.03-1.66,P=0.03,OR:2.30,95%CI:1.04-5.08,P=0.04,and OR:1.41,95%CI:1.00-1.98,P=0.05,respectively) compared to the corresponding homozygous wild-type genotypes.Among never smokers,PXR A7635G and the LXR T-rs1405655-C and T-rs2695121-C variant genotypes were associated with risk of IBD(OR:1.41,95%CI:1.05-1.91,P=0.02,OR:1.63,95%CI:1.21-2.20,P=0.001,and OR:2.02,95%CI:1.36-2.99,P=0.0005,respectively) compared to the respective homozygous variant genotypes.PXR A7635G(rs6785049) variant genotype was associated with a higher risk of UC diagnosis before the age of 40 years and with a higher risk of extensive disease(OR:1.34,95%CI:1.03-1.75 and OR:2.49,95%CI:1.24-5.03,respectively) . CONCLUSION:Common PXR and LXR polymorphisms may contribute to risk of IBD,especially among never smokers.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第2期197-206,共10页 世界胃肠病学杂志(英文版)
基金 supported by the"Familien Erichsen Mindefond",the Lundbeck Foundation the Danish Research Council,the Western Danish Research Forum for Health Science,the County of Viborg,the Danish Colitis-Crohn Association,"John M Klein og hustrus mindelegat" the A.P. Mφller Foundation for the Advancement of Medical Science
关键词 PPAR基因 溃疡性结肠炎 基因多态性 风险 logistic回归模型 炎症 鸡传染性法氏囊病 过氧化物酶体 Crohn's disease Genetic susceptibility Single nucleotide polymorphisms Smoking status Transcription factors Ulcerative colitis
  • 相关文献

参考文献1

二级参考文献79

  • 1[71]Ho GT,Nimmo ER,Tenesa A,Fennell J,Drummond H,Mowat C,Arnott ID,Satsangi J.Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis.Gastroenterology 2005;128:288-296
  • 2[72]Brant SR,Panhuysen CI,Nicolae D,Reddy DM,Bonen DK,Karaliukas R,Zhang L,Swanson E,Datta LW,Moran T,Ravenhill G,Duerr RH,Achkar JP,Karban AS,Cho JH.MDR1 Ala893 polymorphism is associated with inflammatory bowel disease.Am J Hum Genet 2003; 73:1282-1292
  • 3[73]Potocnik U,Ferkolj I,Glavac D,Dean M.Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis.Genes Immun 2004; 5:530-539
  • 4[74]Palmieri O,Latiano A,Valvano R,D'Inca R,Vecchi M,Sturniolo GC,Saibeni S,Bossa F,Latiano T,Devoto M,Andriulli A,Annese V.Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients.Aliment Pharmacol Ther 2005; 22:1129-1138
  • 5[75]Urcelay E,Mendoza JL,Martin MC,Mas A,Martinez A,Taxonera C,Fernandez-Arquero M,Diaz-Rubio M,de la Concha EG.MDR1 gene:susceptibility in Spanish Crohn's disease and ulcerative colitis patients.Inflamm Bowel Dis 2006; 12:33-37
  • 6[76]Farrell RJ,Murphy A,Long A,Dormelly S,Cherikuri A,O'Toole D,Mahmud N,Keeling PW,Weir DG,Kelleher D.High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.Gastroenterology 2000; 118:279-288
  • 7[77]McGovern DP,Ahmad T,Van Heel D,Negoro K,Jewell D.Cytochrome p450 and multidrug-resistance gene 1 (MDR-1)polymorphisms:predictors of the need for colectomy in ulcerative colitis? Gastroenterology 2002; 122:W1313
  • 8[78]Yacyshyn B,Maksymowych W,Bowen-Yacyshyn MB.Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis.Hum Immunol 1999; 60:677-687
  • 9[79]Langmann T,Moehle C,Mauerer R,Scharl M,Liebisch G,Zahn A,Stremmel W,Schmitz G.Loss of detoxification in inflammatory bowel disease:dysregulation of pregnane X receptor target genes.Gastroenterology 2004; 127:26-40
  • 10[1]Schinkel AH.The physiological function of drug-transporting P-glycoproteins.Semin Cancer Biol 1997; 8:161-170

共引文献13

同被引文献29

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部